The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration (scientific article published on 01 December 2015)

Unprecedented binding cooperativity between Cu(I) and Cu(II) in the copper resistance protein CopK from Cupriavidus metallidurans CH34: implications from structural studies by NMR spectroscopy and X-ray crystallography

Q27653889

Diabetes and cancer: a consensus report.

Q27686977

Structural biology of copper trafficking

Q28261249

Yeast cox17 solution structure and Copper(I) binding

Q28909275

Solution structure and backbone dynamics of the Cu(I) and apo forms of the second metal-binding domain of the Menkes protein ATP7A

Q28910418

Data mining of metal ion environments present in protein structures

Q30436127

Amino acid influence on copper binding to peptides: cysteine versus arginine

Q33529997

Magnetic relaxation switches capable of sensing molecular interactions

Q34140565

Folding studies of Cox17 reveal an important interplay of cysteine oxidation and copper binding

Q34418842

Metformin--mode of action and clinical implications for diabetes and cancer

Q34658712

Molecular mechanisms of copper uptake and distribution

Q34662075

Quantification of rolling circle amplified DNA using magnetic nanobeads and a Blu-ray optical pick-up unit

Q35469673

Cellular responses to the metal-binding properties of metformin.

Q35976604

Coordination chemistry of copper proteins: how nature handles a toxic cargo for essential function

Q37972055

Scalable DNA-Based Magnetic Nanoparticle Agglutination Assay for Bacterial Detection in Patient Samples

Q38985606

Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents

Q40569580

Prospects for new antimicrobials based on N,N-dimethylbiguanide complexes as effective agents on both planktonic and adhered microbial strains

Q43110339

Differential pulse voltammetric determination of metformin using copper-loaded activated charcoal modified electrode

Q45204795

High Cu(I) and low proton affinities of the CXXC motif of Bacillus subtilis CopZ.

Q46639329

Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase

Q46968887

Biomolecular reactions studied using changes in Brownian rotation dynamics of magnetic particles.

Q47646947

C-terminal domain of the membrane copper transporter Ctr1 from Saccharomyces cerevisiae binds four Cu(I) ions as a cuprous-thiolate polynuclear cluster: sub-femtomolar Cu(I) affinity of three proteins involved in copper trafficking

Q47974427

Biomolecular mode of action of metformin in relation to its copper binding properties.

Q51122929

Novel readout method for molecular diagnostic assays based on optical measurements of magnetic nanobead dynamics.

Q51502347

Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowägung

Q56483227

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

metformin

Q19484

nanoparticle

Q61231

P304

page(s)

17313-17316

P577

publication date

2015-12-01

P1433

published in

Chemical Communications

Q426303

P1476

title

The copper binding properties of metformin--QCM-D, XPS and nanobead agglomeration

P478

volume

Reverse relations

cites work (P2860)

Q37187900	Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Q90560608	Metformin Affects Heme Function as a Possible Mechanism of Action
Q42362632	Metformin selectively targets redox control of complex I energy transduction
Q41669655	New Evidence for the Mechanism of Action of a Type-2 Diabetes Drug Using a Magnetic Bead-Based Automated Biosensing Platform
Q48365669	Optomagnetic detection of DNA triplex nanoswitches
Q41353984	The mechanisms of action of metformin
Q33787067	To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents

P356	DOI	10.1039/C5CC04321B
P698	PubMed publication ID	26462973